6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
3h ago	Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
4h ago	Refers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
6h ago	The 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
14h ago	Buffalo Potash Files Annual Information Form and New Technical Report
15h ago	Ionik Announces 30-Day Extension of Senior Debt Facility

About

4,404.00ILA+12.00 +0.27%

Closed • Updated at 17:52 GMT+00:00

Market Cap$607.00M

P/E Ratio59.79

Volume101.8K

Beta0.39

RSI41.51

Gross Margin75.50%

Health TechnologyMedical Specialties

Brainsway Ltd — investor relations, events, news, and company updates on 6ix.

Latest News

BrainsWay Announces Minority-Stake Investment in Hopemark Health

BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026

BrainsWay to Participate in the 25th Annual Needham Virtual Healthcare Conference

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate Response to Antidepressants

BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD

Community Chat

Ask AI